Výsledky vyhledávání

POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY

Autor: U. Kiltz, P. Sfikakis, N. Gullick, P. Katsimpri, A. Kotrotsios, J. Brandt-Juergens, E. Lespessailles, N. Maiden, K. Gaffney, D. Peterlik, B. Schulz, E. Pournara, P. Jagiello

Publikováno v: Annals of the Rheumatic Diseases. 81:846-847

BackgroundSERENA is an ongoing, longitudinal, observational study of more than 2900 patients (pts) with moderate to severe psoriasis, active psoriatic arthritis (PsA), and ankylosing spondylitis (AS) conducted at 438 sites across Europe with an expec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66f7606fbad13c88beb1eb1a19ec39ce
https://doi.org/10.1136/annrheumdis-2022-eular.2673

Zobrazit plný text záznamu

AB0752 HOW DOES TIME TO DIAGNOSIS AND GENDER AFFECT TREATMENT OUTCOMES IN PATIENTS WITH ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY WITH SECUKINUMAB

Autor: K. Benesova, O. Hansen, U. Kiltz, J. Brandt-Juergens, P. Kästner, E. Riechers, D. Peterlik, C. Budden, A. Boas, S. Welle, H. P. Tony

Publikováno v: Annals of the Rheumatic Diseases. 81:1501-1502

BackgroundIn both, ankylosing spondylitis (AS) and psoriatic arthritis (PsA), women typically have a longer delay in diagnosis.1,2 There is scientific evidence that prognosis for AS and PsA improves when diagnosed early. The German non-interventional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::26b2d7f0304a934e0539176257669dde
https://doi.org/10.1136/annrheumdis-2022-eular.41

Zobrazit plný text záznamu

POS1013 HOW DOES BODY MASS INDEX AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Autor: U. Kiltz, J. Brandt-Juergens, P. Kästner, E. Riechers, D. Peterlik, C. Budden, H. P. Tony

Publikováno v: Annals of the Rheumatic Diseases. 81:815.2-815

BackgroundThere is a higher prevalence of obesity in patients (pts) with psoriatic disease1. The German non-interventional study AQUILA provides real-world data on the influence of body mass index (BMI) of pts with psoriatic arthritis (PsA) on therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0398b5d4615e9e01bbe497adfa3d26f4
https://doi.org/10.1136/annrheumdis-2022-eular.40

Zobrazit plný text záznamu

AB0751 HOW DOES BODY MASS INDEX AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Autor: U. Kiltz, J. Brandt-Juergens, P. Kästner, E. Riechers, D. Peterlik, C. Budden, H. P. Tony

Publikováno v: Annals of the Rheumatic Diseases. 81:1500.2-1501

BackgroundObesity is a risk factor for worse overall health in people with ankylosing spondylitis (AS)1. The German non-interventional study AQUILA provides real-world data in AS on the influence of body mass index (BMI) on therapeutic effectiveness

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::881ccc1cb391034a243599c9c60f4014
https://doi.org/10.1136/annrheumdis-2022-eular.39

Zobrazit plný text záznamu

POS1023 HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH PSORIATIC ARTHRITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Autor: H-P Tony, Peter Kastner, Uta Kiltz, D. Peterlik, J. Brandt-Juergens, E. Riechers

Publikováno v: Annals of the Rheumatic Diseases. 80:780-781

Background:Gender disparities in PsA can affect natural course of disease, clinical presentation and response to medication1. The German non-interventional study AQUILA provides real-world data on the influence of gender of patients with psoriatic ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a517ef028d86f18a9beac1a21724565
https://doi.org/10.1136/annrheumdis-2021-eular.142

Zobrazit plný text záznamu

POS0899 HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Autor: D. Peterlik, J. Brandt-Juergens, H-P Tony, Uta Kiltz, E. Riechers, Peter Kastner

Publikováno v: Annals of the Rheumatic Diseases. 80:706-707

Background:Current studies suggest that the phenotype of spondyloarthritis differs between genders and that this may influence the subsequent diagnostic approach and therapeutic decisions1. The German non-interventional study AQUILA provides real-wor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e1e2c78b66fea85596024089e216954
https://doi.org/10.1136/annrheumdis-2021-eular.141

Zobrazit plný text záznamu

THU0399 HOW DO TNF-ALPHA-INHIBITORS IN MEDICAL HISTORY AFFECT PATIENT REPORTED OUTCOMES AND RETENTION IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH SECUKINUMAB IN REAL WORLD? - GERMAN AQUILA STUDY

Autor: Uta Kiltz, D. Peterlik, J. Brandt-Juergens, E. Riechers, H-P Tony, Peter Kastner

Publikováno v: Annals of the Rheumatic Diseases. 79:436-437

Background:Secukinumab (SEC), a fully human monoclonal antibody that selectively inhibits interleukin 17A, is approved for treatment of patients with ankylosing spondylitis (AS). However, there is lack of real-world evidence on SEC treatment outcomes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35844043bf8aefdfd070747b2ff1ca38
https://doi.org/10.1136/annrheumdis-2020-eular.220

Zobrazit plný text záznamu

FRI0405 AQUILA STUDY IN GERMANY – REAL WORLD DATA ON SECUKINUMAB’S EFFECTIVENESS IN PSORIATIC ARTHRITIS PATIENTS – RESULTS FROM AN INTERIM ANALYSIS

Autor: Uta Kiltz, Veronika Winkelmann, D. Peterlik, Hans-Peter Tony

Publikováno v: Spondyloarthritis – treatment.

Background Psoriatic arthritis (PsA) is a chronic, progressive, inflammatory disorder of skin and joints, it impacts both physical and emotional well-being, and increases the risk of comorbidities. Thus, improvement of disease activity as well as emo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88e25db939f63f5f30b451d4e2e68d69
https://doi.org/10.1136/annrheumdis-2019-eular.436

Zobrazit plný text záznamu

FRI0406 AQUILA STUDY IN GERMANY – REAL WORLD DATA ON SECUKINUMAB’S EFFECTIVENESS IN ANKYLOSING SPONDYLITIS PATIENTS – RESULTS FROM AN INTERIM ANALYSIS

Autor: D. Peterlik, Hans-Peter Tony, Veronika Winkelmann, Uta Kiltz

Publikováno v: Spondyloarthritis – treatment.

Background Ankylosing spondylitis (AS) is characterized by chronic inflammation of the spine and is at high risk to cause inflammation, pain, and stiffness extraspinal as well. Thus, important aims in therapy of AS are pain reduction and maintenance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b71c3227c0ca25b20a67de8aef160dcc
https://doi.org/10.1136/annrheumdis-2019-eular.437

Zobrazit plný text záznamu

AB0817 DOES SMOKING AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Autor: D. Peterlik, Uta Kiltz, J. Brandt-Juergens, H-P Tony, E. Riechers, Peter Kastner

Publikováno v: Annals of the Rheumatic Diseases. 79:1711.1-1711

Background:Several studies have shown a negative association between smoking status and psoriatic arthritis (PsA) clinical outcomes.1,2The German non-interventional study AQUILA provides real-world data on the influence of smoking on therapeutic effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::073e3fbb0192fde5269e8bca963eac69
https://doi.org/10.1136/annrheumdis-2020-eular.365

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání